Risk factors for infection in haematology patients treated with rituximab.
Kanbayashi Y, Nomura K, Fujimoto Y, Yamashita M, Ohshiro M, Okamoto K, Matsumoto Y, Horiike S, Takagi T, Ishida Y, Taniwaki M; Japan Haematology/Oncology Study (J-HOST) Group.
Kanbayashi Y, et al. Among authors: ohshiro m.
Eur J Haematol. 2009 Jan;82(1):26-30. doi: 10.1111/j.1600-0609.2008.01165.x. Epub 2008 Nov 11.
Eur J Haematol. 2009.
PMID: 19018858